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Among the least characterized herpesvirus membrane proteins are the homologs of UL43 of herpes simplex virus 1 (HSV-1). To identify
and characterize the UL43 protein of pseudorabies virus (PrV), part of the open reading frame was expressed in Escherichia coli and used for
immunization of a rabbit. The antiserum recognized in Western blots a 34-kDa protein in lysates of PrV infected cells and purified virions,
demonstrating that the UL43 protein is a virion component. In indirect immunofluorescence analysis, the antiserum labeled vesicular
structures in PrV infected cells which also contained glycoprotein B. To functionally analyze UL43, a deletion mutant was constructed lacking
amino acids 23–332 of the 373aa protein. This mutant was only slightly impaired in replication as assayed by one-step growth kinetics,
measurement of plaque sizes, and electron microscopy. Interestingly, the PrV UL43 protein was able to inhibit fusion induced by PrV
glycoproteins in a transient expression-fusion assay to a similar extent as gM. Double mutant viruses lacking, in addition to UL43, the
multiply membrane spanning glycoproteins K or M did not show a phenotype beyond that observed in the gK and gM single deletion mutants.
D 2005 Elsevier Inc. All rights reserved.
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Herpesvirus envelope proteins play essential roles in the
initial stages of virus infection, i.e., virion attachment and
penetration (Spear and Longnecker, 2003). However, they
are also important in mediating proper assembly and egress
of virus particles in the late phase of the replicative cycle
(Mettenleiter, 2002, 2004). In the alphaherpesviruses, more
than 10 glycosylated virus-encoded proteins are part of the
virion envelope. Besides these glycoproteins, several non-
glycosylated membrane-associated proteins are also part of
the virion.
Among the least characterized membrane proteins is the
product of the UL43 gene of HSV-1 and its homologues. The
UL43 gene and gene products are conserved only within the
Alpha- and Gammaherpesvirinae subfamilies but are absent0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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tion). The UL43 protein of HSV-1 has been identified by
epitope-tagging as a 30-kDa polypeptide (Carter et al., 1996)
which is substantially smaller than the ca. 40-kDa protein
predicted from the open reading frame. The HSV-1 UL43
mRNAis transcribedwith early kinetics (Carter et al., 1996) as
is the PrV UL43 message (deWind et al., 1994; Powers et al.,
1994). Interestingly, an open reading frame that maps
antisense to the UL43 gene, designated as UL43.5, has been
identified in HSV-1 which is regulated with late kinetics, and
encodes a nuclear protein (Ward et al., 1996). The UL43
homologous protein in Epstein–Barr–Virus (EBV), the prod-
uct of the BMRF2 gene, is a 53- to 55-kDa virion polypeptide
which is associated with intracellular membranes (Johannsen
et al., 2004; Modrow et al., 1992; Tugizov et al., 2003).
The UL43 gene products possess several possible trans-
membrane domains with a hydrophilic loop in the middle of
the protein and an N-terminal hydrophilic extension (Fig.
1A). Studies on the homologous BMRF2 protein of EBV05) 224–233
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playing a role in infection of polarized epithelial cells by
interaction of an RGD motif with cellular integrins (Tugizov
et al., 2003). However, neither the PrV nor the HSV-1
homolog contain this motif and deletion of UL43 in HSV-1
did not impair viral replication either in cell culture or in a
mouse infection model, including no effect on neuroinvasion
and transneuronal spread (MacLean et al., 1991). In PrV,
UL43 has also been shown to be non-essential for virus
growth in cell culture (Powers et al., 1994), although no
animal studies have yet been performed with the PrV mutant.
In our systematic analysis of virion components of PrV,
we aimed at identification and characterization of the UL43
protein. To this end, we obtained an antiserum against the
PrV UL43 protein which was used to identify the PrV UL43
protein as a component of extracellular virions. Intra-
cellularly, the PrV UL43 protein resides in intracytoplasmicFig. 1. Predicted secondary structure of the PrV UL43 protein and construction of
shown as predicted by the program SOSUI (http://sosui.proteome.bio.tuat.ac.jp; H
protein for rabbit immunization are indicated in dark grey. Putative transmembrane
regions (UL, US), and inverted repeat sequences (IR, TR) flanking the US region. T
of the genome region containing the UL43 gene polyadenylation signals for the U
deletion mutant, a XhoI fragment was deleted from the open reading frame.vesicles colocalizing with glycoprotein B. We further
demonstrate that like the multiply membrane spanning
glycoprotein M, the PrV UL43 protein exhibits fusion-
inhibitory activity which may indicate similar functions of
these two virion envelope proteins during virus replication.Results
Identification of the PrV UL43 protein
Amonospecific polyclonal rabbit antiserum was prepared
against a bacterially expressed GST fusion protein contain-
ing amino acids (aa) 147–231 of the deduced PrV UL43
protein. These amino acids are located in a predicted
hydrophilic loop (Fig. 1A) of the otherwise highly hydro-
phobic polypeptide. In purified PrV-Ka virions (Fig. 2, rightUL43 mutant virus. (A) Secondary structure of the deduced UL43 protein is
irokawa et al., 1998). Amino acids of UL43 contained in the GST fusion
domains are boxed. (B) The PrV genome consists of long and short unique
he location of BamHI restriction fragments is indicated. In a magnification
L43 and the upstream UL42 gene are indicated. For construction of a UL43
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panels), the antiserum recognized a ca. 34-kDa protein which
is somewhat smaller than the predicted molecular mass for
the PrV UL43 gene product of 38 kDa. For control, parallel
blots were probed with antibodies against virion glycopro-
teins gM, gK, gB, gC, and gH, as well as against tegument
protein UL37. Purity of the virus preparation was ascertained
by electron microscopy (data not shown) and by lack of
reactivity with an antiserum directed against the primary
envelope protein UL34 (Klupp et al., 2000b). Thus, we
identified for the first time the PrV UL43 protein andFig. 2. Identification of PrV UL43 protein. Purified virions (right panels) or lysates
PrV-DgKw, PrV-DUL43/Mg, PrV-DgK/UL43G, or mock-infected cells were se
nitrocellulose or PVDF membranes, blots were probed with monospecific sera ag
against gB and gC. Location of molecular mass markers is indicated on the left odemonstrated that it is indeed a virion component. In infected
and mock-infected cells, a cellular protein which migrates
slightly faster than the UL43 protein was non-specifically
recognized by the antiserum.
Intracellular localization of the PrV UL43 protein
Using our monospecific antiserum in immunofluores-
cence analyses of PrV-Ka infected cells, prominent immu-
nostaining was observed in intracellular vesicular structures
(Fig. 3A) which was absent in non-infected cells (Fig. 3B)of RK13 cells (left panels) infected with PrV-Ka, PrV-DUL43, PrV-DgMg,
parated by electrophoresis in SDS–polyacrylamide gels. After transfer to
ainst UL43, gM, gK, UL37, UL34, or gH, or with monoclonal antibodies
f each panel.
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below). This punctate intracytoplasmic staining was remi-
niscent of the labeling seen with anti-gB antibodies (Nixdorf
et al., 2000, 2001). Therefore, infected cells were also
analyzed by double-labeling experiments using the anti-
UL43 serum (Fig. 3D) and an anti-gB monoclonal antibody
(Fig. 3E). It is evident that both, at least partly, colocalize in
infected cells indicating that these vesicles contain the UL43
protein as well as gB (Fig. 3F).
To analyze whether this intracytoplasmic localization
also occurs in the absence of other viral gene products, cells
were transfected with expression plasmids for either UL43,Fig. 3. Immunofluorescence analyses. RK13 cells were either infected with PrV
expression plasmids for UL43 (G), gB (H), or gC (I), or cotransfected with expres
microscopy after incubation with monospecific anti-UL43 serum (A–C, G), a mixtu
anti-gC mAb (I), (F, L) Merger of the UL43- and gB-specific signals demonstra
propidium iodide.or gB, or both, and analyzed. As shown in Fig. 3, when
expressed singly (Figs. 3G and H) or in combination (Figs.
3J–L), UL43 and gB also partly (co)localized within these
vesicles. In contrast, gC was found primarily at the plasma
membrane (Fig. 3I). Membrane localization of the UL43
protein was also observed (Fig. 3G).
Isolation and characterization of a PrV UL43 deletion
mutant
For further detailed analysis, we isolated PrV-DUL43, a
UL43 deletion mutant that lacked codons 23–332 of the 373-Ka (A, D–F) or PrV-DUL43 (C) or mock-infected (B), transfected with
sion plasmids for UL43 and gB (J–L), and analyzed by confocal laser scan
re of anti-gB mAb and anti-UL43 antiserum (D–F, J–L), anti-gB mAb (H), or
ted in (D, E) and (J, K), respectively. Chromatin was counterstained with
Fig. 4. Plaque size of mutant viruses on non-complementing and complementing cells. RK13, RK13-UL43, RK13-gM, or RK13-gK cells were infected with
the indicated viruses under plaque assay conditions. Plaques were measured microscopically 2 days pi. Relative plaque sizes were calculated and compared to
those of PrV-Ka which were set as 100%. Average values and standard deviation of at least two independent experiments are shown.
B.G. Klupp et al. / Virology 334 (2005) 224–233228amino acid UL43 protein (Fig. 1B). As shown in Fig. 2, no
UL43 gene product was detectable in either PrV-DUL43
virions or PrV-DUL43 infected cells, although, compared to
PrV-Ka, controls showed a similar amount of viral proteins
gM, gK, UL37, gB, gC, and gH. This verified the specificity
of the antiserum and the lack of UL43 expression in the
deletion mutant.Fig. 5. One-step growth kinetics of mutant viruses. RK13, RK13-UL43, RK13-g
viruses, harvested at the indicated times after infection, and titrated. Average valuNeither the HSV-1 nor the PrV UL43 protein is required
for viral replication in cell culture (MacLean et al., 1991;
Powers et al., 1994). This correlates with our findings that
plaque size (Fig. 4) and one-step growth kinetics (Fig. 5) of
PrV-DUL43 are only marginally impaired compared to PrV-
Ka. Plaque size is reduced by approximately 10% and viral
titers are decreased by ca. 2- to 5-fold. These defects wereM, or RK13-gK cells were infected with PrV-Ka or the respective mutant
es and standard deviations of three independent experiments are shown.
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ing that, although slight, they are indeed due to the UL43
deletion. Correlating with these results, in ultrastructural
analyses PrV-DUL43 infected non-complementing cells
showed all stages of virion formation (data not shown).
PrV UL43 protein inhibits fusion in an in vitro assay
We previously established an in vitro fusion assay using
PrV glycoproteins gB-008 and gDH (Klupp et al., 2000a).
In this assay, we detected strong fusion inhibiting activity of
the multiply membrane spanning envelope glycoprotein gM
of PrV, or the gM/gN complex of equine herpesvirus 1 and
infectious laryngotracheitis virus (Klupp et al., 2000a). To
test for a similar activity of the PrV UL43 protein,
expression plasmids for gB-008 and gDH were cotrans-
fected either with or without addition of expression
plasmids encoding gM, gN, gM and gN, UL43, gK,
UL20, or gK and UL20 (Dietz et al., 2000). As shown in
Fig. 6, inclusion of the UL43 expression plasmid decreased
fusion efficiency by ca. 80%, i.e., to a similar extent as a gM
expression plasmid. In contrast, the multiply membrane
spanning proteins gK and UL20 did not impair fusion when
cotransfected singly with the fusion proteins. However,
cotransfection of both gK and UL20 decreased fusion by ca.
70% which is in line with our previous observation that
proper intracellular processing of PrV gK requires coex-
pression of the UL20 gene product (Dietz et al., 2000).
Characterization of PrV double mutants in multiply
membrane spanning envelope proteins
Since the UL43 protein, gM, and gK/UL20 inhibited
fusion in an in vitro assay, there could be functional
redundancy between these proteins. To test for this in theFig. 6. Fusion assay. Expression plasmids for the fusion inducing gB-008
and gDH proteins of PrV were cotransfected with empty pcDNA3 control
and expression plasmids for gM, gN, UL43, gK, and UL20 or with pairs of
expression plasmids for gM and gN, or gK and UL20. Fusion was
quantitated as described in Materials and methods. Average values and
standard deviations of three independent experiments are shown.viral background, we constructed and analyzed double
mutants lacking UL43 and either gM or gK. As shown in
Fig. 2, in PrV-DgK/UL43G infected non-complementing
cells the UL43 and gK proteins were absent, but other viral
envelope constituents such as gB, gC, gH, gM, and UL37
were present in amounts comparable to wild-type PrV Ka. A
similar result was obtained when purified virions were
analyzed (Fig. 2). In PrV-DUL43/Mh infected cells the
UL43 and gM proteins were missing but gB, gC, gH, gK,
and UL37 were expressed and were also present in purified
virions (Fig. 2).
Deletion of gM alone only moderately impaired plaque
formation of PrV and additional deletion of UL43 did not
further decrease plaque size (Fig. 4). In the absence of gK,
plaque formation of PrV was drastically impaired (Dietz et
al., 2000; Klupp et al., 1998), no matter whether UL43 was
present or absent. Plaque formation of gM-deleted viruses
was enhanced on RK13-gMw cells, and plaque formation of
gK-deleted viruses was fully restored on RK13-gK cells
again without apparent involvement of UL43.
In one-step growth analyses (Fig. 5) similar results were
obtained. On non-complementing cells PrV-DgK/43G pro-
duced titers similar to PrV-DgK indicating that the addi-
tional deletion of UL43 had no augmenting effect on the gK
defect. On RK13-gKw cells, PrV-DgK/43G replicated to
slightly lower titers than PrV-Ka, which reflects the slight
growth defect attributable to the absence of UL43. A similar
result was obtained with PrV-DUL43/Mh. Ultrastructural
analyses confirmed these findings (data not shown). Thus,
the additional deletion of UL43 had no effect on the
replication of gK- or gM-deleted virus mutants.Discussion
The UL43 protein which is conserved in alpha- and
gammaherpesviruses but absent in betaherpesviruses (Baer et
al., 1984; Chee et al., 1990; McGeoch et al., 1988) is one of
the least characterized of the alphaherpesvirus gene products
which have been proven or predicted to be transmembrane
proteins. Although the genomic sequence of the respective
PrV protein has been known for some time (Powers et al.,
1994), no gene product has so far been identified. Using a
monospecific antiserum prepared against a predicted hydro-
philic loop which separates two clusters of five and four
predicted hydrophobic transmembrane regions (Fig. 1), we
identified the PrV UL43 protein as a 34-kDa protein which is
present in infected cells and purified virions. This is the third
identification of a UL43 protein after the homologous HSV-1
(Carter et al., 1996) and EBV proteins (Modrow et al., 1992)
and is the first description of a UL43 protein as a constituent
of alphaherpes virions. Our finding thus adds to the
complexity of the alphaherpesvirus envelope. It is likely that
the HSV-1 homolog of the PrV UL43 protein is also present
in the virion as has been shown for the homologous EBV
protein BMRF 2 (Johannsen et al., 2004).
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previous findings that the UL43 gene is not required for
virus growth in cell culture (MacLean et al., 1991; Powers et
al., 1994). Viral titers were only ca. 2- to 5-fold lower than
those of the isogenic wild-type PrV-Ka, and plaque size was
also only marginally reduced. However, these slight defects
were due to absence of UL43 and not to fortuitous other
alterations in the viral genome since they could be corrected
on UL43 expressing cells. Thus, absence of the UL43
protein is not without any effect on viral replication. In EBV,
it has been suggested that the BMRF 2 protein is involved in
attachment and entry into polarized epithelial tongue and
nasopharyngeal cells by binding to cellular integrin (Tugi-
zov et al., 2003). In contrast, deletion of the HSV-1 UL43
protein had no effect in a mouse infection model (MacLean
et al., 1991), arguing against an important role of UL43 for
in vivo infection. However, studies in a natural virus-host
system using appropriate deletion and rescue mutants have
not yet been performed.
In HSV-1, an open reading frame antisense to UL43,
designated as UL43.5, has been detected which expresses a
protein that colocalizes with capsid proteins in the nucleus
(Ward et al., 1996). Like UL43, UL43.5 is also dispensable
for viral replication in cell culture. However, in PrV there is
no indication of expression of an UL43.5-like open reading
frame antisense to UL43 (Klupp et al., 2004; Powers et al.,
1994).
Despite its non-essential character the conservation of
UL43 homologs within the alpha- and gammaherpesviruses
is striking. Apparently, their role is either limited to certain
aspects of the viral life cycle as may be the case for the EBV
BMRF2 protein (Tugizov et al., 2003), or their function is
redundant and also executed by other viral proteins. We
analyzed a possible redundancy of function following the
observation that the UL43 protein inhibits membrane fusion
in a transient expression-fusion system involving PrV
envelope glycoproteins. Coexpression of UL43 reduces
fusion to a similar extent as coexpression of gM (Klupp et
al., 2000a; this paper). In the case of gM, this fusion
inhibition correlates with retention of fusogenic viral
envelope proteins in the Golgi apparatus (Crump et al.,
2004). Moreover, we show that fusion is also inhibited by
coexpression of gK and UL20 as has recently been
demonstrated for the homologous HSV-1 proteins (Avitabile
et al., 2004). Since gM and gK also represent multiply
membrane spanning proteins like the UL43 protein, it is
possible that their roles are related. However, character-
ization of mutant viruses lacking UL43 and either gM or gK
yielded no phenotype indicative of synergy or redundancy.
A mutant lacking all three of these proteins has not yet been
constructed. Thus, it is still possible that the three proteins
share an important function which can still be executed even
in the absence of two of them.
Interestingly, the UL43 protein was found in infected
and transfected cells in vesicular structures in the cyto-
plasm. A similar subcellular localization has previouslybeen observed for gB, and we show here that the two
proteins indeed colocalize. Whether this reflects a physical
and/or functional interaction is unclear at present. gB is an
essential part of the fusion complex which is required for
penetration and for direct viral cell-to-cell spread (Spear
and Longnecker, 2003). It is endocytosed via signals
contained in the intracytoplasmic carboxy-terminal part of
the protein (Nixdorf et al., 2000; Van Minnebruggen et al.,
2004). Mutation of these endocytosis signals results in a
higher density of gB at the plasma membrane and increased
cell–cell fusion (Nixdorf et al., 2000; Van Minnebruggen et
al., 2004). We did not observe any striking effect of the
deletion of UL43 on fusion processes during virus
infection, although, as discussed above, this could be due
to functional redundancy with other viral proteins. Thus,
the observed colocalization may indeed be functionally
relevant.
In summary, we identified the PrV UL43 protein and
showed that it is a virion constituent. Although deletion of
UL43 from the viral genome did not result in a robust
phenotype, in transient expression assays the UL43 protein
strongly inhibited membrane fusion induced by the viral
fusion machinery to a similar extent as gM. Thus, it is
conceivable that the PrV UL43 protein is involved in
modulating fusion processes during infection.Materials and methods
Viruses and cells
All viruses used in this study were derived from PrV
strain Kaplan (PrV-Ka; Kaplan and Vatter, 1959). Con-
struction of virus mutants lacking genes coding for
glycoproteins gM and gK as well as generation of
recombinant cell lines constitutively expressing gM or gK
have been described elsewhere (Dietz et al., 2000; Dijkstra
et al., 1997). Viruses were propagated on rabbit kidney cells
(RK13), genetically engineered RK13 cells expressing viral
proteins, or porcine kidney cells (PSEK) in minimum
essential medium supplemented with 10% or 5% fetal calf
serum, respectively. Construction of mutants lacking UL43,
UL43 and gM, or UL43 and gK is described below. An
RK13 cell line which constitutively expresses UL43 was
isolated after transfection of RK13 cells with pcDNA-UL43.
In this plasmid, the PCR amplified UL43 open reading
frame was cloned under control of the immediate–early
promotor–enhancer complex of human cytomegalovirus. To
this end, PCR was performed using primers UL43For1 (5V-
CACAGAATTCCGCCGTCGCGATGATCTCC-3V, nt
52832-52850; GenBank Accession No. BK001744; Klupp
et al., 2004) and UL43Rev1 (5V-CACATCTAGAGAG-
CGTGGGCGTGAATCAGG-3V, nt 53978-53959; Accession
No. BK001744), pfx DNA polymerase (Invitrogen, Karls-
ruhe, Germany), and cloned BamHI-fragment 2 (see Fig.
1B) as template. The 1166-bp PCR product was digested
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the primers (underlined), and cloned into appropriately
cleaved eukaryotic expression vector pcDNA3 (Invitrogen)
giving rise to plasmid pcDNA-UL43. UL43 start and stop
codons are shown in bold. Transfected cells were selected
with medium containing 0.5 mg G418 (Invitrogen) per ml,
and resistant cell clones were tested with the anti-UL43
serum (see below) in indirect immunofluorescence and
Western blotting (data not shown). One cell clone was
selected for further experiments and designated RK13-
UL43.
Construction of UL43 mutants
For deletion of the PrV UL43 open reading frame a 2.7-
kb PstI/KpnI subfragment of BamHI-fragment 2 (Fig. 1B)
was cloned into pUC19 (New England Biolabs, Frankfurt,
Germany) resulting in plasmid pPK2.7. This plasmid was
digested with XhoI thereby deleting codons 23–332 of the
373 aa UL43 open reading frame generating plasmid
pPK2.7DXhoI. Into the reconstituted XhoI site a GFP
expression cassette was inserted. The resulting plasmid
pDUL43gfp and PrV-Ka DNA were used for cotransfection
into RK13 cells using calcium phosphate coprecipitation
(Graham and van der Eb, 1973). Transfection progeny was
screened for green fluorescing plaques, which were
purified to homogeneity resulting in the isolation of PrV-
DUL43G. To delete the introduced heterologous GFP
gene, genomic DNA of PrV-DUL43G was cotransfected
with plasmid pPK2.7DXhoI, and transfection progeny was
screened for non-fluorescing plaques. One plaque isolate
was designated PrV-DUL43 and used for further studies. In
this mutant, the 23 5V-terminal codons are retained and
fused out-of-frame to the 40 3V-terminal codons, which
theoretically could result in a fusion protein containing the
amino terminal 23 aa of UL43 and 18 non-UL43 C-
terminal amino acids.
To isolate a mutant simultaneously lacking UL43 and gM
genomic DNA of PrV-DUL43 was cotransfected with
plasmid pDUL10h (Dijkstra et al., 1997) into RK13-gM
cells (Brack et al., 1999) and screened for blue plaques. One
plaque isolate, designated PrV-DUL43/Mh, was further
characterized. A mutant simultaneously lacking UL43 and
gK was isolated after cotransfection of PrV-DgKw viral
DNA and plasmid pDUL43gfp into RK13-gK cells (Dietz et
al., 2000) followed by purification of green fluorescing
plaques. The resulting double mutant was named PrV-DgK/
UL43G. DNA of all recombinants was analyzed by South-
ern blot hybridizations to verify correct deletion of genomic
sequences and insertion of marker genes.
Preparation of antiserum
The PrV UL43 gene product is predicted to possess
multiple membrane spanning domains (Powers et al., 1994).
To generate an antiserum against PrV UL43 part of theprotein predicted to be hydrophilic and not embedded in a
membrane was expressed as GST-fusion protein in Escher-
ichia coli (Fig. 1A). To this end, DNA encoding aa 147–231
was PCR-amplified using primers UL43For2 (5V-CACA-
GAATTCGGGCCCTCGTGAACGTGCG-3V; nt 53278-
53296; Accession No. BK001744) and UL43Rev2 (5V-
CACACTCGAGCTGCCGGCGTAGGCGTGG-3V; nt
53534-53516, Accession No. BK001744) and pfx DNA
polymerase (Invitrogen) using cloned BamHI-fragment 2 as
template. The resulting 275 bp PCR product was digested
with EcoRI and XhoI using the artificially introduced
restriction sites (underlined) and cloned into appropriately
cleaved prokaryotic expression vector pGEX-4T-2. The 35-
kDa GST-UL43147–231 fusion protein was purified and used
for immunization of a rabbit as described (Klupp et al.,
2001).
Indirect immunofluorescence and confocal laser scan
microscopy
RK13 cells grown on cover slips were infected with
PrV-Ka or PrV-DUL43 at an MOI of 10, or transfected with
expression plasmids for UL43 and gB. Four hours after
infection or 48 h after transfection they were fixed for 20
min with 3% paraformaldehyde (PFA) followed by 10 min
incubation with 3% PFA with 0.3% Triton X-100. The
fixed cells were subsequently incubated with monospecific
antiserum against UL43 and/or monoclonal antibodies
against gB (Nixdorf et al., 2000) or gC (Klupp and
Mettenleiter, 1999) for 1 h at room temperature followed
by Alexa 488-conjugated anti-rabbit and/or Alexa 594-
conjugated anti-mouse secondary antibodies (Molecular
Probes, Leiden, The Netherlands). Fluorescence was
preserved with a 9:1 mixture of glycerol and PBS
containing 2.5 mg 1,4-diazabicyclooctane per ml. The
slides were analyzed with a confocal laser scan microscope
(LSM510; Zeiss, Gfttingen, Germany).
Virus purification and immunoblotting
Virus purification and preparation of infected cell lysates
was performed as described (Kopp et al., 2003). Parallel
blots were incubated with monospecific antisera against
UL43 (this study), gM (Kopp et al., 2003), gK (D4-1; Dietz
et al., 2000), UL37 (Klupp et al., 2001), gH (Klupp and
Mettenleiter, 1999), and UL34 (Klupp et al., 2000b), or
monoclonal antibodies against gB (b43-b5; Nixdorf et al.,
2000) and gC (B16-c8; Klupp and Mettenleiter, 1999). For
detection of the highly hydrophobic gK, gM, and UL43
proteins, gels were blotted onto PVDF membranes (Immo-
bilon P, Millipore, Eschborn, Germany).
One-step growth and plaque assays
One-step growth analyses were performed as described
previously (Klupp et al., 2001). Wild-type or comple-
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after infection at an MOI of 5. Progeny virus titers were
determined on RK13 cells. The mean titers and
corresponding standard deviation of three independent
experiments were plotted. For determination of plaque
sizes cells were infected at a low MOI and incubated
under a methylcellulose overlay for 2 days. Infected
cells were fixed with 2.5% formaldehyde and stained
with 1% crystal violet in 50% ethanol. Plaques were
measured microscopically, and mean diameters including
standard deviation of three independent experiments were
calculated.
Fusion assay
Fusion assays were performed as described previously
(Klupp et al., 2000a,b) using expression plasmids for a
C-terminally truncated gB protein, gB-008 (Nixdorf et al.,
2000), and gDH, a hybrid protein consisting of the N-
terminal 271 amino acids of gD fused to the 590 C-
terminal amino acids of gH (Klupp and Mettenleiter,
1999). This two-component fusion system exhibits greater
fusion activity than obtained with the wild-type proteins
gB, gH, and gL. The two expression plasmids were
cotransfected as indicated with empty vector pcDNA3, or
expression vectors for gM (Klupp et al., 2000a,b), gN
(Jo¨ns et al., 1998), UL20 (Dietz et al., 2000), gK (Dietz
et al., 2000), and UL43 (this study). 750 ng of each
plasmid was used for the assay. Transfected cells were
incubated for 40 h at 37 8C. They were then fixed with
80% ethanol and incubated with a monoclonal anti-
body against gB (A20-c26; Nixdorf et al., 2000) followed
by Alexa 488-conjugated anti-mouse IgG (Molecular
Probes).
For quantification of the fusion assays random digital
photographs of the immunostained cells were taken using a
C3040Zoom camera (Olympus, Hamburg, Germany)
mounted on an inverted microscope IX50 (Olympus) at a
magnification of 100. In each assay the area of 50
polykaryocytes of more than 2 nuclei was determined using
the measurement function of the DP-Soft (Version 3.2)
software (Olympus). A maximum of 25 syncytia per picture
were measured starting with the largest object. Three
independent assays were performed and the result of each
assay was calculated compared to the fusion activity of gB-
008 and gDH which was set as 100%. Mean values and
standard deviation are given.Acknowledgments
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